Oncology - BMT/SCT News & Articles

41 Phase II study of CD4+guided pentostatin lymphodepletion and pharmacokinetically-targeted busulfan as conditioning for hematopoietic cell allografting Biology of Blood and Marrow Transplantation, May 2, 2013    Clinical Article

42 A Pilot Study of Prophylactic Ex Vivo Co-Stimulated Donor Leukocyte Infusions After Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation Biology of Blood and Marrow Transplantation, May 2, 2013    Clinical Article

43 The migration of hematopoietic progenitors from the fetal liver to the fetal bone marrow: Lessons learned and possible clinical applications Experimental Hematology, May 2, 2013    Review Article

44 Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation International Journal of Hematology, May 2, 2013    Clinical Article

45 Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation Hematological Oncology, May 1, 2013    Clinical Article

46 Acute graft-versus-host disease in a nonhematopoietic stem cell transplantation candidate treated with decitabine followed by granulocyte colony-stimulating factor-primed peripheral blood stem cells infusion: a special entity of the disease Transfusion, May 1, 2013

47 The relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies Biology of Blood and Marrow Transplantation, May 1, 2013    Review Article

48 Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3-CD19 depletion Hematology, May 1, 2013    Clinical Article

49 Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia International Journal of Hematology, May 1, 2013    Clinical Article

50 Late-onset hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation in patients with advanced leukemia: differences in ATG dosage are key International Journal of Hematology, May 1, 2013    Clinical Article

51 Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission American Journal of Hematology, April 30, 2013    Clinical Article

52 Physical Performance of Nontransplanted Childhood ALL Survivors is Comparable to Healthy Controls Journal of Pediatric Hematology/Oncology, April 30, 2013    Clinical Article

53 Quality of life and its socio-demographic and psychological determinants after bone-marrow transplantation European Journal of Haematology, April 29, 2013    Clinical Article

54 Irreversible Leukoencephalopathy After Reduced-intensity Stem Cell Transplantation in a Dyskeratosis Congenita Patient With TINF2 Mutation Journal of Pediatric Hematology/Oncology, April 29, 2013    Clinical Article

55 Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation International Journal of Hematology, April 29, 2013    Clinical Article

56 Spontaneous Subcapsular Splenic Hematoma Associatedwith Filgrastim in a Patient Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Annals of Pharmacotherapy, April 26, 2013

57 A French Cohort of Childhood Leukaemia Survivors: Impact of Haematopoietic Stem Cell Transplantation (HSCT) on Health Status and Quality of Life Biology of Blood and Marrow Transplantation, April 26, 2013    Review Article    Clinical Article

58 Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy International Journal of Hematology, April 26, 2013    Clinical Article

59 Second time a charm Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agent Transfusion, April 25, 2013    Clinical Article

60 Acute myeloid leukemia associated with FGFR1 abnormalities International Journal of Hematology, April 25, 2013    Clinical Article

1 Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma Bone Marrow Transplantation, April 3, 2013

2 Disease status and stem cell source impact on the results of reduced intensity conditioning transplant for Hodgkin lymphoma: a retrospective study from the French Society of Bone Marrow Graft Transplantation and Cellular Therapy Haematologica, April 4, 2013    Free full text    Review Article

3 Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose Biology of Blood and Marrow Transplantation, April 1, 2013

4 Clinical Guide to ABO Incompatible Allogeneic Stem Cell Transplantation Biology of Blood and Marrow Transplantation, April 12, 2013

5 Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse Haematologica, April 15, 2013    Free full text    Review Article

6 Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation Journal of Clinical Oncology, March 19, 2013

7 Comparison of outcomes after two standards-of-care RIC regimens and two different graft sources (FB2A2-PBSC vs dUCB-TCF) for allogeneic stem cells transplantation (allo-SCT) in adults with haematological diseases: a single centre analysis Biology of Blood and Marrow Transplantation, April 2, 2013

8 Increase of suicide and accidental death after hematopoietic stem cell transplantation Cancer, March 25, 2013

9 Allogeneic Hematopoietic Cell Transplantation for Fanconi Anemia in Patients With Pretransplantation Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute Leukemia Journal of Clinical Oncology, April 5, 2013

10 Autologous retransplantation for patients with recurrent multiple myeloma Cancer, April 15, 2013

11 Application of five prognostic survival scores to primary myelofibrosis in 62 Brazilian patients Medical Oncology, April 12, 2013

12 Three-Dimensional Virtual Bone Bank System Workflow for Structural Bone Allograft Selection: A Technical Report Sarcoma, April 19, 2013

13 Busulfan Dose Intensity and Outcomes in Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for MDS/AML Biology of Blood and Marrow Transplantation, April 8, 2013

14 Impact of pre-transplant marrow blasts on survival of allogeneic stem cell transplantation in adult acute myeloid leukemia International Journal of Hematology, April 3, 2013

15 Mitigating effects of hUCB-MSCs on the hematopoietic syndrome resulting from total body irradiation Experimental Hematology, April 15, 2013

16 Characteristics of chronic GVHD after cord blood transplantation Bone Marrow Transplantation, April 18, 2013

17 Autologous Umbilical Cord Blood (UCB) Infusion Followed by Oral Docosahexanoic Acid (DHA) and Vitamin D (VitD) Supplementation for C-Peptide Preservation in Children with Type 1 Diabetes (T1D) Biology of Blood and Marrow Transplantation, April 24, 2013

18 The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation American Journal of Hematology, April 1, 2013

19 Determining the optimal time for bortezomib-based induction chemotherapy followed by autologous hematopoietic stem cell transplant in the treatment of multiple myeloma Chinese Journal of Cancer Research, April 16, 2013    Free full text

20 A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Transplant International, April 9, 2013